Two of Moderna’s mRNA-based HIV vaccines could start human trials this week, according to a new posting in the National Institutes of Health’s clinical trial registry. The Phase I study would test the vaccines’ safety, as well as collect basic data on whether they’re inducing any kind of immunity, but would still need to go through Phases II and III to see how effective they might be.
The Trump Administration’s early reaction to the outbreak of a new coronavirus that’s near certain to hit the U.S. hard hasn’t been great, to put it lightly. Continue reading A Coronavirus Vaccine Should Be Free, Not ‘Affordable’
Medical supply transportation is a serious problem in remote regions, where it may take weeks to transport a vaccine where it’s most needed. But a British student has developed a simple device that might help get supplies where they need to go and save millions of lives in the process.
An Ebola survivor’s blood and a new technique for isolating immune cells may have opened up new ways to combat the deadly virus.
The U.S. is currently embroiled in an opioid epidemic—the drugs were involved in 28,647 deaths in 2014, up 200 percent from the year 2000. And while researchers have developed painkillers that are harder to abuse andmedications that reduce the effects of opioids once a person has overdosed, there is currently nothing on the market to stop opioids’ effects altogether. Now a team of researchers is hoping to change that.
CUBA HAS FOR several years had a promising therapeutic vaccine against lung cancer. The 55-year trade embargo led by the US made sure that Cuba was mostly where it stayed. Until—maybe—now.